Skip to main content

Hereditary Cancer in Clinical Practice

Ausgabe 1/2023

Inhalt (27 Artikel)

Open Access Case Report

Germline heterozygous exons 8–11 pathogenic BARD1 gene deletion reported for the first time in a family with suspicion of a hereditary colorectal cancer syndrome: more than an incidental finding?

Sergio Carrera, Ana Belén Rodríguez-Martínez, Intza Garin, Esther Sarasola, Cristina Martínez, Hiart Maortua, Almudena Callejo, Abigail Ruiz de Lobera, Alberto Muñoz, Nagore Miñambres, Pablo Jiménez-Labaig

Open Access Review

Are population level familial risks and germline genetics meeting each other?

Kari Hemminki, Xinjun Li, Asta Försti, Charis Eng

Open Access Research

Pathological complete response to neoadjuvant chemotherapy in triple negative breast cancer – single hospital experience

Elina Sivina, Lubova Blumberga, Gunta Purkalne, Arvids Irmejs

Open Access Research

COVID-19 vaccination uptake and safety profile among germline BRCA1 and BRCA2 pathogenic variant carriers in Singapore

Zewen Zhang, Nur Diana Binte Ishak, Frances Victoria Fajardo Que, Zi Yang Chua, Sock Hoai Chan, Jianbang Chiang, Joanne Ngeow Yuen Yie

Open Access Research

Comparing telemedicine and in-person gastrointestinal cancer genetic appointment outcomes during the COVID-19 pandemic

Samantha Williams, Jessica E. Ebrahimzadeh, Daniel Clay, Gillian Constantino, Jordan Heiman, Kirk J. Wangensteen, Kathleen Valverde, Nadim Mahmud, Bryson W. Katona

Open Access Comment

Size matters in telomere biology disorders ‒ expanding phenotypic spectrum in patients with long or short telomeres

Anna Byrjalsen, Anna Engell Brainin, Thomas Kromann Lund, Mette Klarskov Andersen, Anne Marie Jelsig

Open Access Case Report

Beyond germline genetic testing - heterozygous pathogenic variants in PMS2 in two children with Osteosarcoma and Ependymoma

Michaela Kuhlen, Mariola Monika Golas, Tina Schaller, Nicole Stadler, Felicitas Maier, Olaf Witt, Michael C. Frühwald

Open Access Comment

Genetic testing for hereditary breast cancer in Poland: 1998–2022

Jacek Gronwald, Cezary Cybulski, Tomasz Huzarski, Anna Jakubowska, Tadeusz Debniak, Marcin Lener, Steven A Narod, Jan Lubinski

Open Access Review

BRCA1/2 potential founder variants in the Jordanian population: an opportunity for a customized screening panel

Olfat Ahmad, Christian Sutter, Steffen Hirsch, Stefan M. Pfister, Christian P. Schaaf

Open Access Review

Genotype–phenotype correlation of BMPR1a disease causing variants in juvenile polyposis syndrome

M. E. Papadopulos, J. P. Plazzer, F. A. Macrae

Open Access Case Report

Lynch-like syndrome with germline WRN mutation in Bulgarian patient with synchronous endometrial and ovarian cancer

Zornitsa Bogomilova Kamburova, Polina Damyanova Dimitrova, Diana Strateva Dimitrova, Katya Stefanova Kovacheva, Savelina Lubenova Popovska, Slavena Enkova Nikolova

Open Access Research

Using a multistep approach with multidisciplinary team to increase the diagnosis rate of Lynch syndrome-associated colorectal cancer after universal screening: a single-center study in Japan

Kyota Tatsuta, Mayu Sakata, Moriya Iwaizumi, Risa Kojima, Katsumasa Yamanaka, Satoshi Baba, Katsunori Suzuki, Yoshifumi Morita, Hirotoshi Kikuchi, Yoshihiro Hiramatsu, Kiyotaka Kurachi, Hiroya Takeuchi

Open Access Research

Factors affecting adherence to a high-risk surveillance protocol among patients with Li-Fraumeni syndrome

Kaylee A. Underkofler, Martha H. Thomas, Christina J. Taylor, Christa L. Mazur, Sarah H. Erickson, Kari L. Ring

Open Access Case Report

A novel pathogenic frameshift variant in AXIN2 in a man with polyposis and hypodontia

M. F. Broekema, E. J. W. Redeker, M. T. Uiterwaal, L. P. van Hest

Open Access Case Report

Familial pancreatic cancer: a case study and review of the psychosocial effects of diagnoses on families

Tracy Lowe, Jane DeLuca, Ludovico Abenavoli, Luigi Boccuto

Open Access Case Report

Periampullary tumors in a patient with pancreatic divisum and neurofibromatosis type 1: a case report

Bin-bin Li, Hui Zheng, Yi-Dan Lou, Wen-Wei Zhang, Song Zheng

Open Access Review

Dominantly inherited micro-satellite instable cancer – the four Lynch syndromes - an EHTG, PLSD position statement

Pal Møller, Toni T. Seppälä, Aysel Ahadova, Emma J. Crosbie, Elke Holinski-Feder, Rodney Scott, Saskia Haupt, Gabriela Möslein, Ingrid Winship, Sanne W. Bajwa-ten Broeke, Kelly E. Kohut, Neil Ryan, Peter Bauerfeind, Laura E. Thomas, D. Gareth Evans, Stefan Aretz, Rolf H. Sijmons, Elizabeth Half, Karl Heinimann, Karoline Horisberger, Kevin Monahan, Christoph Engel, Giulia Martina Cavestro, Robert Fruscio, Naim Abu-Freha, Levi Zohar, Luigi Laghi, Lucio Bertario, Bernardo Bonanni, Maria Grazia Tibiletti, Leonardo S. Lino-Silva, Carlos Vaccaro, Adriana Della Valle, Benedito Mauro Rossi, Leandro Apolinário da Silva, Ivana Lucia de Oliveira Nascimento, Norma Teresa Rossi, Tadeusz Dębniak, Jukka-Pekka Mecklin, Inge Bernstein, Annika Lindblom, Lone Sunde, Sigve Nakken, Vincent Heuveline, John Burn, Eivind Hovig, Matthias Kloor, Julian R. Sampson, Mev Dominguez-Valentin

Open Access Research

The prevalence of lynch syndrome (DNA mismatch repair protein deficiency) in patients with primary localized prostate cancer using immunohistochemistry screening

Suguru Oka, Shinji Urakami, Kiichi Hagiwara, Michikata Hayashida, Kazushige Sakaguchi, Yuji Miura, Naoko Inoshita, Masami Arai

Open Access Review

Diagnosis of patients with Lynch syndrome lacking the Amsterdam II or Bethesda criteria

Miguel Angel Trujillo-Rojas, María de la Luz Ayala-Madrigal, Melva Gutiérrez-Angulo, Anahí González-Mercado, José Miguel Moreno-Ortiz

Open Access Research

Prevalence of BRCA1 and BRCA2 germline variants in an unselected pancreatic cancer patient cohort in Pakistan

Noor Muhammad, Ayesha Azeem, Shumaila Arif, Humaira Naeemi, Iqra Masood, Usman Hassan, Bushra Ijaz, Faisal Hanif, Aamir Ali Syed, Muhammed Aasim Yusuf, Muhammad Usman Rashid

Open Access Case Report

Simultaneous bilateral mastectomy and RRSO for BRCA2-positive non-invasive breast cancer in Japan: a case report and analysis of initial experience

Aya Tanaka, Megumi Matsumoto, Mami Takao, Shoko Miura, Yuri Hasegawa, Ryota Otsubo, Hiroko Hayashi, Ichiro Isomoto, Kiyonori Miura, Takeshi Nagayasu

Open Access Research

“Go ahead and screen” - advice to healthcare systems for routine lynch syndrome screening from interviews with newly diagnosed colorectal cancer patients

Jennifer L. Schneider, Alison J. Firemark, Sara Gille, James Davis, Pamala A. Pawloski, Su-Ying Liang, Mara M. Epstein, Jan Lowery, Christine Y. Lu, Ravi N. Sharaf, Andrea N. Burnett-Hartman, Victoria Schlieder, Zachary M. Salvati, Deborah Cragun, Alanna Kulchak Rahm, Jessica Ezzell Hunter

Open Access Research

Progression of duodenal neoplasia to advanced adenoma in patients with familial adenomatous polyposis

Hiroko Nakahira, Yoji Takeuchi, Yusaku Shimamoto, Shingo Ishiguro, Hiroshi Yunokizaki, Yasumasa Ezoe, Fumie Fujisawa, Ryu Ishihara, Tetsuji Takayama, Teruhiko Yoshida, Michihiro Mutoh, Hideki Ishikawa

Open Access Review

SMAD4 variants and its genotype–phenotype correlations to juvenile polyposis syndrome

Kimberley Cao, John-Paul Plazzer, Finlay Macrae

Open Access Research

Experiences of patients and family members with follow-up care, information needs and provider support after identification of Lynch Syndrome

Ryan Mooney, Yelena P. Wu, Kelsey Kehoe, Molly Volkmar, Wendy Kohlmann, Cathryn Koptiuch, Kimberly A Kaphingst

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.